39 related articles for article (PubMed ID: 18804405)
1. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
[TBL] [Abstract][Full Text] [Related]
2. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
Kiani Ghalesardi O; Zaker F; Ghotaslou A; Boustani H; Rezvani MR; Kiani J; Shahidi M
Gene; 2023 Sep; 880():147622. PubMed ID: 37419428
[TBL] [Abstract][Full Text] [Related]
3. CD10-bearing fibroblast inhibits matrigel invasive potency of interleukin-1α-producing squamous cell carcinoma by diminishing substance P levels in the tumor microenvironment.
Xie L; Moroi Y; Tsuji G; Liu M; Hayashida S; Takahara M; Fukagawa S; Takeuchi S; Shan B; Nakahara T; Uchi H; Yokomizo T; Furue M
Cancer Sci; 2010 Dec; 101(12):2570-8. PubMed ID: 20874839
[TBL] [Abstract][Full Text] [Related]
4. Host-Cell-Dependent Roles of E-Cadherin in
Tsaplina O; Lomert E; Berson Y
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069398
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer.
Yin X; Jiang K; Zhou Z; Yu H; Yan D; He X; Yan S
Oxid Med Cell Longev; 2023; 2023():3878796. PubMed ID: 36713030
[TBL] [Abstract][Full Text] [Related]
6. Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers.
Nana AW; Wu SY; Yang YS; Chin YT; Cheng TM; Ho Y; Li WS; Liao YM; Chen YR; Shih YJ; Liu YR; Pedersen J; Incerpi S; Hercbergs A; Liu LF; Whang-Peng J; Davis PJ; Lin HY
Horm Cancer; 2018 Oct; 9(5):349-360. PubMed ID: 30027502
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma.
Chen J; Xiao Y; Cai X; Liu J; Chen K; Zhang X
BMC Cancer; 2017 Dec; 17(1):855. PubMed ID: 29246119
[TBL] [Abstract][Full Text] [Related]
8. p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
Chen J; Li S; Xiao Y; Zou X; Zhang X; Zhu M; Cai M; Xie D
BMC Cancer; 2017 Dec; 17(1):846. PubMed ID: 29237424
[TBL] [Abstract][Full Text] [Related]
9. E2F1 regulates p53R2 gene expression in p53-deficient cells.
Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies.
Aye Y; Li M; Long MJ; Weiss RS
Oncogene; 2015 Apr; 34(16):2011-21. PubMed ID: 24909171
[TBL] [Abstract][Full Text] [Related]
11. [Ribonucleotide reductase and non-small cell lung cancer].
Hsu NY; Lee H; Cheng YW; Yen Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):619-23. PubMed ID: 23092586
[No Abstract] [Full Text] [Related]
12. p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer.
Hsu NY; Wu JY; Liu X; Yen Y; Chen CY; Chou MC; Lee H; Cheng YW
Oncol Lett; 2010 Jul; 1(4):609-613. PubMed ID: 22966352
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.
Liu X; Kolokythas A; Wang J; Huang H; Zhou X
Curr Cancer Ther Rev; 2010 Nov; 6(4):294-307. PubMed ID: 21709736
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer.
Liu X; Lai L; Wang X; Xue L; Leora S; Wu J; Hu S; Zhang K; Kuo ML; Zhou L; Zhang H; Wang Y; Wang Y; Zhou B; Nelson RA; Zheng S; Zhang S; Chu P; Yen Y
Cancer Res; 2011 May; 71(9):3202-13. PubMed ID: 21415168
[TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Yoshida H; Mizuno A
Oral Oncol; 2009 Jun; 45(6):521-5. PubMed ID: 18804405
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
[TBL] [Abstract][Full Text] [Related]
17. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
[TBL] [Abstract][Full Text] [Related]
18. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
[TBL] [Abstract][Full Text] [Related]
19. Akt and p53R2, partners that dictate the progression and invasiveness of cancer.
Yousefi B; Samadi N; Ahmadi Y
DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
